← Open Payments lookup

MARY HELMREICH: Open Payments

NPI 1225604408 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,660 in 109 payments from 15 companies in 2025. Trend: 2023 $1,410 · 2024 $2,049 · 2025 $2,660

Food & beverage: $2,660
CompanyPaymentsAmount
ABBVIE INC.39$659
Gilead Sciences, Inc.7$311
Janssen Biotech, Inc.16$302
Phathom Pharmaceuticals, Inc.6$259
Madrigal Pharmaceuticals6$201
Ipsen Biopharmaceuticals, Inc6$196
GENZYME CORPORATION5$173
QOL Medical, LLC9$169
Salix Pharmaceuticals, a division of Bausch Health US, LLC7$139
Novo Nordisk Inc1$118

Products named: RINVOQ, TREMFYA, VOQUEZNA, REZDIFFRA, DUPIXENT, Sucraid, XIFAXAN, Bylvay.

Industry payments across NV — which companies pay providers there.